China Health Technology Sets Out Board and Committee Structure

Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks China Bozza Development Holdings Limited ( (HK:1069) ) has issued an announcement. China Health Technology Group Holding Company Limited has announced the current composition of its board of directors, led by executive director and chairman cum chief executive officer Ms. Bu Xue, alongside fellow executive and independent non-executive directors. The company also detailed the structure of its three key board committees, with independent director Mr. Chau Wing Nam chairing the audit, remuneration, and nomination committees, underscoring an emphasis on independent oversight and corporate governance. These governance arrangements highlight the central role of independent directors in supervising critical functions such as financial reporting, executive pay, and board appointments. The clarified allocation of responsibilities among committee members provides stakeholders with greater transparency around decision-making processes and may reinforce investor confidence in the group’s governance framework. More about China Bozza Development Holdings Limited China Health Technology Group Holding Company Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates in the health technology sector. The company is overseen by a board comprising executive and independent non-executive directors, reflecting a typical governance structure for a listed healthcare-related group. Average Trading Volume: 563,358 Technical Sentiment Signal: Sell Current Market Cap: HK$97.26M